A New York Times Bestselling Author -- Is it possible to manipulate private life insurance information to allow investors to benefit from the deaths of others? Two Wall Street whiz-kids turn their focus on the multi-trillion dollar life insurance industry. By securitizing policies of the old and infirm, they hope to make a killing. Meanwhile, two exceptional medical residents work with a premier scientist on cutting-edge research that could revolutionize health care. When their mentor dies suddenly, they quietly investigate. And as they dig deeper, it becomes clear that his death was not from natural causes.
